Literature DB >> 7523011

Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes.

S Ohsako1, M Hara, M Harigai, C Fukasawa, S Kashiwazaki.   

Abstract

Studies indicate that autoimmune phenomena might be caused by a failure to eliminate autoreactive lymphocytes. Therefore, we examined Fas antigen and bcl-2 expression and function in lymphocytes from human systemic lupus erythematosus (SLE) patients. Freshly isolated lymphocytes from patients with active SLE expressed more Fas antigen than did lymphocytes from patients with inactive SLE or from normal controls. They also showed characteristic DNA fragmentation after treatment with anti-Fas antibody. Expression of bcl-2 in T cells from active SLE patients was significantly higher than that in cells from inactive SLE patients and from normals. These data suggest that lymphocytes in patients with active SLE maintain an activated state in vivo. However, the role of Fas and bcl-2 expression in the regulation of lymphocyte survival in SLE is still unclear and further investigations concerning the role of these molecules in autoimmune phenomenon in SLE are needed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523011     DOI: 10.1006/clin.1994.1176

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  12 in total

Review 1.  T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens.

Authors:  Syamal K Datta; Li Zhang; Luting Xu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

2.  Both perforin and FasL are required for optimal CD8 T cell control of autoreactive B cells and autoantibody production in parent-into-F1 lupus mice.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Roman Puliaev; Irina Puliaeva; Charles S Via
Journal:  Clin Immunol       Date:  2018-06-22       Impact factor: 3.969

3.  Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE).

Authors:  M Bijl; G Horst; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

4.  Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE).

Authors:  Q R Huang; D Morris; N Manolios
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

5.  Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.

Authors:  J Wu; J Wilson; J He; L Xiang; P H Schur; J D Mountz
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

6.  Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings.

Authors:  N A Fathi; M R Hussein; H I Hassan; E Mosad; H Galal; N A Afifi
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

7.  Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis.

Authors:  Nan Xiang; Xiao-Mei Li; Guo-Sheng Wang; Jin-Hui Tao; Xiang-Pei Li
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

Review 8.  The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus.

Authors:  Bernadete L Liphaus; Maria Helena Bittencourt Kiss
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

9.  Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis.

Authors:  M Yachida; K Kurokohchi; K Arima; M Nishioka
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

10.  Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.

Authors:  L Georgescu; R K Vakkalanka; K B Elkon; M K Crow
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.